From: Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients
Age, years | 71 (61–77) |
Female/male, n | 11/33 |
Dialysis vintage, months | 36 (20–72) |
Body mass index, kg/m2 | 25.0 (23.0–29.5) |
Diabetes mellitus, n | 23 |
Cardiovascular disease, n | 30 |
Primary kidney disease, n | |
Diabetes mellitus | 12 |
Chronic glomerulonephritis | 5 |
Nephrosclerosis | 7 |
Polycystic kidney disease | 4 |
Vasculitis | 2 |
Other or unknown disease | 14 |
Medications, n | |
Beta-blockers | 25 |
ACEi/ARBs | 9 |
Statins | 15 |